Drug Profile
Research programme: small molecule therapeutics - Orexia/X-Chem
Latest Information Update: 22 Sep 2022
Price :
$50
*
At a glance
- Originator X-Chem
- Class Sleep disorder therapies; Small molecules
- Mechanism of Action Orexin receptor type 2 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Narcolepsy